生物技术公司Dianthus Therapeutics Inc.近日更新了其关键研发管线的时间表。公司宣布，其备受关注的Momentum试验2期研究的顶线数据预计将在2026年第四季度公布。这项试验是评估其候选疗法在特定适应症中有效性与安全性的重要里程碑。
与此同时，公司还透露了另一项名为Captivate的项目的进展。关于Captivate的更新信息预计将在2026年年内完成并对外公布。这两个重要节点的预期，为关注该公司研发进展的投资者与行业观察者提供了明确的时间框架。
上述进展预计将对公司的未来发展方向和潜在价值产生重要影响。市场将持续关注Dianthus Therapeutics在这些关键时间点所披露的数据与信息。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.